Drug LitigationMore Safety Studies Pending for Transvaginal Mesh Products

October 1, 2012

Major manufacturers of transvaginal mesh implants, a widely distributed medical product that has affected thousands of women, have notified the U.S. government’s health care agency, the Food and Drug Administration (FDA), that they plan to review both the safety of implants and the appropriateness of current and possible labels.

 

Manufacturers have come under intense pressure after thousands of women experienced adverse health affects following their transvaginal mesh operation. For many of these women, the operation was intended to address their pelvic organ prolapse (POP) or stress urinary incontinence (SUI), but instead only added pain, discomfort, and embarrassment.

 

Are you suffering from the painful after effects of your transvaginal mesh surgery? The attorneys at the law firm of Nachawati Law Group know what you’ve experienced and how the law can protect your rights. For your free consultation to learn how we can help you, contact us today. Just call 1.866.545.8364 or email [email protected] . We can help.

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.